Pharmadrug (Pharmadrug) YoY EBITDA Growth : 90.70% (As of Sep. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Pharmadrug YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Pharmadrug's YoY EBITDA Growth for the quarter that ended in Sep. 2023 was 90.70%.

Pharmadrug's EBITDA per Share for the three months ended in Sep. 2023 was $-0.00.

Pharmadrug YoY EBITDA Growth Historical Data

The historical data trend for Pharmadrug's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmadrug YoY EBITDA Growth Chart

Pharmadrug Annual Data

Trend

Sep13

Sep14

Sep15

Sep16

Sep17

Dec18

Dec19

Dec20

Dec21

Dec22

YoY EBITDA Growth

Get a 7-Day Free Trial

-552.85

65.56

62.44

57.67

36.23

Pharmadrug Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
YoY EBITDA Growth	Get a 7-Day Free Trial															-186.67	273.68	92.00	61.54	90.70

Pharmadrug YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Pharmadrug's YoY EBITDA Growth for the fiscal year that ended in Dec. 2022 is calculated as:

	YoY EBITDA Growth (A: Dec. 2022 )
=	(EBITDA per Share (A: Dec. 2022 )	-	EBITDA per Share (A: Dec. 2021 ))	/	\| EBITDA per Share (A: Dec. 2021 ) \|
=	(-0.044	-	-0.069)	/	\| -0.069 \|
=	36.23 %

Pharmadrug's YoY EBITDA Growth for the quarter that ended in Sep. 2023 is calculated as:

	YoY EBITDA Growth (Q: Sep. 2023 )
=	(EBITDA per Share (Q: Sep. 2023 )	-	EBITDA per Share (Q: Sep. 2022 ))	/	\| EBITDA per Share (Q: Sep. 2022 )) \|
=	(-0.004	-	-0.043)	/	\| -0.043 \|
=	90.70 %

Pharmadrug YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Pharmadrug's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmadrug (Pharmadrug) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmadrug Inc (OTCPK:LMLLF) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

G11:Germany PHRX:Canada

Address

77 King Street West, Suite 2905, Toronto, ON, CAN, M5K 1H1

Website

https://www.pharmadrug.ca

Pharmadrug Inc is a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics and naturally derived approved drugs. The Company's operations comprise of the corporate division in Canada. Geographically, it operates in Germany and Canada.